Convenio Suministro Farmacos Controlados
Qué, el Hospital de Quilpué requiere realizar un llamado a licitación pública para la contratación del CONVENIO SUMINISTRO FARMACOS CONTROLADOS con el objetivo de cumplir y satisfacer debidamente la demanda asistencial que legalmente le ha sido encomendada; lo anterior, según los nuevos medicamentos ingresados al arsenal de farmacia
14 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1047027-540-SE23 | 17-07-2023 | Laboratorio Chile S.A. | $130.881 |
| 1047027-634-SE23 | 17-07-2023 | Laboratorio Biosano S.A. | $33.320 |
| 1047027-633-SE23 | 17-07-2023 | Laboratorio Chile S.A. | $23.800 |
| 1047027-643-SE23 | 04-07-2023 | Johnson y Johnson de Chile S.A. | $146.156 |
| 1047027-646-SE23 | 04-07-2023 | Laboratorio Biosano S.A. | $47.600 |
| 1047027-645-SE23 | 04-07-2023 | Laboratorio Sanderson S.A. | $94.248 |
| 1047027-627-SE23 | 04-07-2023 | Laboratorio Chile S.A. | $1.011.500 |
| 1047027-635-SE23 | 04-07-2023 | Insuamérica SpA | $1.368.500 |
| 1047027-541-SE23 | 22-06-2023 | Insuamérica SpA | $1.627.920 |
| 1047027-481-SE23 | 19-06-2023 | Laboratorio Chile S.A. | $129.948 |
| 1047027-526-SE23 | 19-06-2023 | Laboratorio Chile S.A. | $1.011.500 |
| 1047027-509-SE23 | 19-06-2023 | Insuamérica SpA | $1.368.500 |
| 1047027-473-SE23 | 01-06-2023 | Fresenius Kabi Chile Limitada | $130.900 |
| 1047027-404-SE23 | 09-05-2023 | Insuamérica SpA | $547.400 |
| 1047027-402-SE23 | 08-05-2023 | Laboratorio Chile S.A. | $708.050 |
| 1047027-296-SE23 | 26-04-2023 | Laboratorio Chile S.A. | $130.881 |
| 1047027-303-SE23 | 18-04-2023 | Laboratorios Andromaco S.A. | $271.320 |
| 1047027-320-SE23 | 12-04-2023 | Johnson y Johnson de Chile S.A. | $219.234 |
| 1047027-295-SE23 | 11-04-2023 | Fresenius Kabi Chile Limitada | $130.900 |
| 1047027-246-SE23 | 31-03-2023 | Laboratorio Chile S.A. | $130.881 |
| 1047027-256-SE23 | 28-03-2023 | Insuamérica SpA | $466.480 |
| 1047027-245-SE23 | 27-03-2023 | Laboratorio Chile S.A. | $809.200 |
| 1047027-210-SE23 | 14-03-2023 | Laboratorios Andromaco S.A. | $624.750 |
| 1047027-136-SE23 | 22-02-2023 | Laboratorios Andromaco S.A. | $406.980 |
| 1047027-37-SE23 | 16-01-2023 | Laboratorios Andromaco S.A. | $406.980 |
| 1047027-41-SE23 | 09-01-2023 | Laboratorio Chile S.A. | $583.100 |
| 1047027-987-SE22 | 29-12-2022 | Laboratorio Chile S.A. | $1.618.400 |
| 1047027-891-SE22 | 06-12-2022 | Laboratorios Andromaco S.A. | $271.320 |
| 1047027-584-SE22 | 08-09-2022 | Laboratorio Chile S.A. | $261.762 |
| 1047027-597-SE22 | 08-09-2022 | Laboratorios Andromaco S.A. | $1.249.500 |
| 1047027-563-SE22 | 12-08-2022 | Laboratorio Biosano S.A. | $232.050 |
| 1047027-555-SE22 | 12-08-2022 | Fresenius Kabi Chile Limitada | $130.900 |
| 1047027-528-SE22 | 04-08-2022 | Insuamérica SpA | $543.830 |
| 1047027-513-SE22 | 02-08-2022 | Johnson y Johnson de Chile S.A. | $292.312 |
| 1047027-514-SE22 | 02-08-2022 | Laboratorios Andromaco S.A. | $406.980 |
| 1047027-508-SE22 | 25-07-2022 | Laboratorio Sanderson S.A. | $534.786 |
| 1047027-481-SE22 | 21-07-2022 | Johnson y Johnson de Chile S.A. | $292.312 |
| 1047027-480-SE22 | 14-07-2022 | Laboratorio Biosano S.A. | $232.050 |
Fuente original:ficha mercadopublico.cl
